QTTB Q1 2020 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$83M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$588,000+117.8% YoY

Gross Profit

$00.0% margin

Operating Income

-$36M-6206.1% margin

Net Income

-$35M-6008.7% margin

EPS (Diluted)

$-14.09

QoQ Revenue Growth

+4.4%

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$28M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$289M

Total Liabilities

$62M

Stockholders' Equity

$227M

Cash & Equivalents

$143M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$588,000	$270,000	+117.8%
Gross Profit	$0	$0	—
Operating Income	-$36M	-$25M	-45.3%
Net Income	-$35M	-$24M	-48.1%